fashion -WSS

fashion

author：focus 2025-09-29 20:50:43 - browse：5794

A purple number 3 with an eye is surrounded by smaller, black number 3s on a green background — 3 to watch coverage from STAT — Christine Kao/STAT

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather for the J.P. Morgan Healthcare Conference to pick apart the year that was and prognosticate about the one to come. The consensus, in good markets and bad, is almost always cautious optimism for boom times ahead, a prediction that in recent years has had groundhog-level accuracy.

But after two years of steady decline, 2024 might finally prove them right. Biotech is on the upswing, driven by the rise of some headline-grabbing medicines, the advance of cutting-edge technologies, and a few reminders that big drug companies are still willing to pay billions of dollars for small ones.

Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Decentralized clinical trials need collaboration to achieve wider use

hotspot

explore

WSS

Winning ticket for $1 billion Powerball jackpot sold in California

The Bio Revolution is changing business and society

Lawsuit challenges CMS nursing home minimum staffing rule

Stanford president's case begs question: Who takes blame?

Lawsuit challenges CMS nursing home minimum staffing rule

Asahi Kasei to buy Calliditas, picking up kidney disease drug

hotspot

fashion

hotspot

Activists slam private health insurers over coverage restrictions

Awakening the world to the whoosh: A patient's crusade

Drug repurposing or repositioning? The language matters

Affordable Connectivity Program vital to health care, experts say

In age of alternative facts, a scholarly course on calling out crap

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Alkermes shareholders re

Should insurance cover cosmetic surgery?

Hollywood unions extend contract negotiations for actors

Pharma’s losing bet in New Jersey

entertainment

Clinicians often fail to acknowledge the pain caused by long Covid

Study identifies new proteins linked to dementia risk 25 years later

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Louisiana bill approved classifying abortion pills as controlled substances

hotspot

explore

knowledge

hotspot